期刊文献+

那可丁对宫颈癌HeLa细胞的抑制作用及机制探讨 被引量:4

Inhibitory Effects of Noscapine on Human Cervical Cancer Cell Line HeLa and Its Mechanism
暂未订购
导出
摘要 目的探讨那可丁对宫颈癌HeLa细胞株的抑制作用及其机制。方法体外培养人宫颈癌HeLa细胞株,梯度浓度那可丁干预后,MTT测定细胞存活率,软琼脂克隆形成实验检测细胞成瘤能力,Western blot检测Caspase-3、PARP(多聚ADP-核糖聚合酶)蛋白水平变化,流式细胞术检测细胞凋亡率及细胞周期分布。结果 MTT检测发现那可丁显著降低HeLa细胞存活率(P<0.05),该效应具有浓度依赖性和时间依赖性;软琼脂克隆形成实验发现,10、20、30、40μmol/L那可丁组的细胞克隆计数依次为(19±3)、(13±2)、(4±1)(、3±1),均显著低于对照组的(62±8)(均P<0.01);流式细胞术检测显示那可丁显著增加细胞凋亡率(P<0.05),该效应具有浓度依赖性和时间依赖性;Western blot检测显示那可丁上调Caspase-3(17 kD)、PARP(85 kD)蛋白水平;流式细胞术检测显示那可丁阻滞HeLa细胞周期于G2/M期(P<0.05)。结论那可丁对HeLa细胞有显著抑制效应;那可丁诱导的G2/M期周期阻滞可能在该效应中发挥作用。 Objective To investigate the effects of noscapine on human cervical cancer cell line HeLa and its mechanism.Methods HeLa cells were cultured in vitro and treated with gradient concentrations of noscapine.MTT assay was used to detect the proliferation of HeLa cells.Soft-agar colony-forming assay was used to measure tumor-forming ability.Flow cytometry(FCM)was used to measure apoptosis and cell cycle distribution of HeLa cells.Western blot was used to detect protein levels of Caspase-3 and poly ADP-ribose polymerase(PARP).Results MTT assay showed that noscapine decreased the survival rate of HeLa cells in a time-and dose-dependent manner(P〈0.05).Soft-agar colony-forming assay displayed that clone number of HeLa cells treated with 10,20,30 or 40 μmol/L noscapine was(19±3),(13±2),(4±1) and(3±1) respectively,that was(62±8) in group control,which indicated a significantly decreased tumor-forming ability of HeLa cells(P〈0.01).FCM analysis revealed that noscapine increased apoptosis rate of HeLa cells in a time-and dose-dependent manner(P〈0.05).Western blot analysis demonstrated that noscapine increased protein levels of Caspase-3(17 kD)and PARP(85 kD)in HeLa cells.Noscapine arrested HeLa cells in G2/M phase(P〈0.05).Conclusion Noscapine significantly inhibits HeLa cells.Noscapine-induced G2/M phase arrest may play an important role in the effects.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2011年第3期287-290,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家自然科学基金资助项目(No.30770942) 武汉市青年科技晨光计划资助项目(No.200750731294)
关键词 那可丁 宫颈癌 细胞周期 细胞凋亡 noscapine uterine cervical neoplasms cell cycle apoptosis
  • 相关文献

参考文献13

  • 1Kitchener H C, Hoskins W,Small W Jr,et al. The develop- ment of priority cervical cancer trials= a Gynecologic Cancer InterGroup report[J]. Int J Gynecol Cancer, 2010, 20(t3) 1092-1100.
  • 2Rydzewska L, Tierney J, Vale C L, et al. Neoadjuvant ehemo therapy plus surgery versus surgery for eervieal cancer[J]. Coehrane Database Syst Rev, 2010, ( 1 ) : CD007406.
  • 3魏少荫,李敏.微管抑制剂那可丁及其衍生物的抗肿瘤作用研究进展[J].中国新药杂志,2006,15(15):1238-1243. 被引量:7
  • 4黄磊,敖启林,刘德艳,卢运萍,马丁.低氧对卵巢癌A2780细胞周期阻滞的影响[J].华中科技大学学报(医学版),2005,34(1):79-83. 被引量:4
  • 5Cohen M H ,Johnson J R,Pazdur R. U. S. Food and Drug Ad ministration Drug Approval Summery: conversion of imatinib mesylate(STI571 ; Gleevee) tablets from accelerated approval to full approval[J]. Clin Cancer Res, 2005,11 ( 1 ) : 12-19.
  • 6Cohen M H,Williams G A,Sridhara R,et al. FDA drug ap- proval summary:gefitinib(ZD1839) (Iressa) tablets[J]. Oncol- ogist,2003,8(4) :30:3-306.
  • 7Tulpule A,Lavine A M,Berman N E et al. Phase 1 study of noscapine for patients with non Hodgkin ' s lymphoma or chronic lymphocytic leukemia re{ractory to chemotherapy[J]. Blood,2005,106(11) :3341.
  • 8Landen J W, Hau V, Wang M, et al. Noscapine cross the blood-brain barrier and inhibits glioblastoma growth[J]. Clin Cancer Res,2004,10(15):5187-5201.
  • 9Ye K,Ke Y,Keshava N,et al. Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells[J]. Proe Natl Acad Sci USA, 1998,95(4).- 1601-1606.
  • 10Zhou J, Gupta K, Yao J, et al. Paclitaxel-resistant human o varian cancer ceils undergo c Jun NH2-terminal kinase-media- ted apoptosis in response to noscapine[J]. J Biol Chem, 2002, 277(42) :39777-39785.

二级参考文献40

  • 1Shannon A M,Bouchier-Hayes D J,Condron C M et al. Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. Cancer Treat Rev, 2003, 29: 297.
  • 2Goda N, Ryan H E, Khadivi B et al. Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia. Mol Cell Biol, 2003, 1: 359.
  • 3Comerford K M, Wallace T J, Karhausen J et al. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res, 2002, 12: 3387.
  • 4Yang Zhizhang, Zou Aiping. Transcriptional regulation of heme oxygenases by HIF-1α in renal medullary interstitial cells. Am J Physiol Renal Physiol , 2001, 281:F900.
  • 5Memarzadeh S, Berek J S. Advances in the management of epithelial ovarian cancer. J Reprod Med, 2001, 7: 621.
  • 6Teicher B A. Hypoxia and drug resistance. Cancer Metastasis Rev, 1994, 2: 139.
  • 7Harris A L. Hypoxia--a key regulatory factor in tumor growth. Nat Rev Cancer,2002, 2: 38.
  • 8Semenza G L. HIF-1, O2, and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell, 2001, 107:1.
  • 9Iida T, Mine S, Fujimoto H et al. Hypoxia-inducible factor-1alpha induces cell cycle arrest of endothelial cells. Genes Cells, 2002, 2: 143.
  • 10Powis G, Kirkpatrick L. Hypoxia inducible factor-1alpha as a cancer drug target. Mol Cancer Ther,2004, 3:647.

共引文献9

同被引文献44

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部